Skip to main content
Signal8

Lemerond Nicole

SEC insider (Form 3/4/5 filer). CIK 0001941712. Director at MEDICINOVA INC (MNOV) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 23, 2026. Located in SMYRNA, GA.

Companies Lemerond Nicole has filed insider reports for

  • MEDICINOVA INC (MNOV): Director
  • GeoVax Labs, Inc. (GOVX): Director
  • InMed Pharmaceuticals Inc. (INM): Director
Lemerond Nicole profile photo

Lemerond Nicole

CIK: 0001941712

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

MEDICINOVA INC logo
MNOV

MEDICINOVA INC

Director
GeoVax Labs, Inc. logo
GOVX

GeoVax Labs, Inc.

Director
InMed Pharmaceuticals Inc. logo
INM

InMed Pharmaceuticals Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • MEDICINOVA INC logo
    MNOV

    MEDICINOVA INC

    Jun 23, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    44.5K shares-
  • GeoVax Labs, Inc. logo
    GOVX

    GeoVax Labs, Inc.

    Jun 17, 2026
    Award

    Stock Option

    Direct
    6K shares-
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Dec 19, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    1.8K shares-
  • MEDICINOVA INC logo
    MNOV

    MEDICINOVA INC

    Jun 17, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    20K shares-
  • GeoVax Labs, Inc. logo
    GOVX

    GeoVax Labs, Inc.

    Jun 5, 2025
    Award

    Stock Option

    Direct
    10K shares-
  • MEDICINOVA INC logo
    MNOV

    MEDICINOVA INC

    Feb 12, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    24.5K shares-
  • InMed Pharmaceuticals Inc. logo
    INM

    InMed Pharmaceuticals Inc.

    Dec 20, 2024
    Award

    Employee Stock Option (Right to Buy)

    Direct
    550 shares-

1-7 of 7